Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
46 studies found for:    Open Studies | "Impotence"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Impotence"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Bioabsorbable Everolimus-Eluting Stents for Internal Pudendal Artery-Related Arteriogenic Erectile Dysfunction
Condition: Impotence, Arteriogenic
Intervention: Device: Bioabsorbable everolimus-eluting stent deployment
2 Recruiting Stress Management Using an App to Improve Response With PDE5 Inhibitors in Men With Erectile Dysfunction.
Condition: Erectile Dysfunction
Intervention: Behavioral: Utilization of Serenita for Relaxation
3 Recruiting Evaluation for Restoration of Erectile Dysfunction After Cardioversion Treatment Trial
Condition: Erectile Dysfunction
Intervention: Other: Erectile dysfunction
4 Recruiting Penile Intracavernosal Stem Cells Therapy for Erectile Dysfunction
Condition: Erectile Dysfunction
Intervention: Procedure: liposuction for retrieval of own stem cells from fat cells
5 Recruiting Autologous Adipose-Derived Stromal Cells Delivered Into the Corpus Cavernous in Patients With Erectile Dysfunction
Condition: Erectile Dysfunction
Interventions: Other: Liposuction;   Biological: AD-SVF Cell Injection
6 Recruiting Use of Wharton Jelly in Erectile Dysfunction
Condition: Erectile Dysfunction
Intervention: Biological: Wharton Jelly Mesenchymal stem cells
7 Recruiting Effectiveness And Safety Of Two Protocols For The Treatment Of Erectile Dysfunction With Low-Density Shock Waves
Condition: Erectile Dysfunction
Intervention: Procedure: Low-Intensity Extracorporeal Shock Wave Therapy (Li-ESWT)
8 Recruiting Fundus Oculi and Erectile Dysfunction
Condition: Erectile Dysfunction
Interventions: Device: Dynamic Vessel Analyzer (DVA);   Drug: Phosphodiesterase type 5 Inhibitor (PDE5I)
9 Recruiting Assessment of Penile Vibratory Stimulation Using the Viberect in Men With Mild-Moderate and No Erectile Dysfunction
Condition: Organic Erectile Dysfunction
Intervention: Device: Viberect
10 Recruiting Low Energy Shockwave Therapy for Improving Erectile Dysfunction
Condition: Erectile Dysfunction
Interventions: Other: Pre-inclusion questionnaires;   Drug: 1 month of PDE5i treatment;   Other: PDE5i follow-up questionnaires;   Other: Inclusion questionnaires;   Device: 4 weekly LIESWT (Wave 1) with the RENOVA device;   Device: 4 weekly sham LIESWT (Wave 1) with the RENOVA device;   Other: Follow-up questionnaires 1 month after Wave 1;   Other: Follow-up questionnaires 3 months after Wave 1;   Device: 8 bi-weekly LIESWT (Wave 2) with the RENOVA device;   Other: Follow-up questionnaires 1 month after Wave 2;   Other: Questionnaires via postal mail;   Other: Final follow-up questionnaires 12 months after Wave 2
11 Not yet recruiting Safety and Clinical Efficacy of Local Topical Treatment for Erectile Dysfunction
Condition: Erectile Dysfunction
Intervention: Drug: VL#FIA3-30
12 Recruiting Safety of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Erectile Dysfunction
Condition: Erectile Dysfunction
Intervention: Drug: mesenchymal stem cell (Cellgram-ED)
13 Not yet recruiting Low Frequency Shock Wave Therapy for Improving Post-prostatectomy Erectile Dysfunction: a Prospective Pilot Study
Condition: Erectile Dysfunction
Intervention: Device: 8 bi-weekly LIESWT sessions
14 Recruiting Safety and Efficacy of TD0025 (Rocket1h) for Treatment of Erectile Dysfunction
Condition: Erectile Dysfunction
Interventions: Drug: TD0025;   Drug: Sildenafil Citrate 50mg
15 Recruiting Clinical Trial of Topically-applied Glyceryl Trinitrate (GTN) for the Treatment of Erectile Dysfunction (ED)
Condition: Erectile Dysfunction
Interventions: Drug: Glyceryl trinitrate;   Drug: MED Placebo
16 Recruiting A Phase 2a, Single-Dose, Double-Blind, Placebo-Controlled, 2-Way Crossover Study Using Penile Plethysmography to Evaluate the Efficacy and Safety of SST-6006, a Topical Sildenafil Cream (5% w/w), Compared to Placebo in the Treatment of Erectile Dysfunction
Condition: Erectile Dysfunction
Interventions: Drug: Sildenafil;   Drug: Placebo
17 Recruiting Prevalence Of Internal Pudendal Artery Disease In Patients With Erectile Dysfunction Undergoing Diagnostic Coronary Angiography
Condition: To Assess the Presence of Internal Pudendal Artery Disease in Patients With Erectile Dysfunction Undergoing Coronary Angiography
Intervention:
18 Recruiting The Early Diagnosis and Warning Role of Erectile Dysfunction
Conditions: Erectile Dysfunction;   Endothelial Dysfunction
Intervention:
19 Recruiting Impact of a Sexology Consultation on Disease Control of Type 2 Male Diabetics With Erectile Dysfunction
Conditions: Erectile Dysfunction;   Type 2 Diabetes
Intervention: Procedure: Sexology consultation
20 Recruiting Effect of Tadalafil on Erectile Dysfunction Treatment and QOL Improvement Effect (by SF-12) in Andropause Patients With Erectile Dysfunction
Conditions: Erectile Dysfunction;   Andropause
Intervention: Drug: Tadalafil

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.